Stay Updated
Press Releases
WASHINGTON D.C. — Today, following the announcement of the new lower prices negotiated through Medicare – which marked a historic shift in drug pricing policy – P4AD patient advocate Judy Aiken, who takes Enbrel, one of the first 10 negotiated drugs, introduced President Biden and Vice President Harris at an event focused on the new […]
Press Releases
On Average Prices Are Reduced By More Than 60 Percent, With Two Drugs Slashed By More Than 75 Percent Per Month WASHINGTON D.C. — Today, the Biden-Harris administration released the results of its first-ever drug price negotiations through Medicare, marking a historic shift in drug pricing policy and promising significant savings for nearly nine million American patients. The new […]
Press Releases
Federal Judge Tosses Another Lawsuit Against Medicare Negotiation, Slams Industry for Trying To “Manipulate the System” WASHINGTON D.C. — Marking the seventh consecutive win against the multi-million dollar legal campaign to block Medicare negotiation, on Thursday, August 8th, a federal district judge in Ohio dismissed the legal challenge to Medicare’s authority to negotiate lower drug […]
Press Releases
Federal Judge Deals Another Blow To Pharmaceutical Industry Lawsuits, Upholds Medicare’s Drug Price Negotiation Program WASHINGTON D.C. — Marking another win in the fight against Big Pharma’s multi-million dollar legal campaign to end Medicare negotiation, on Wednesday, July 31st, a federal judge in New Jersey ruled against Novo Nordisk’s legal challenge to Medicare’s authority to […]
Press Releases
Federal Judge Upholds Medicare’s Drug Price Negotiation Program, Ruling For Patients And Rejecting Pharmaceutical Industry Lawsuit WASHINGTON D.C. — Dealing another major blow to Big Pharma’s coordinated legal assault on Medicare negotiation, on Wednesday, July 3rd, a federal judge in Connecticut ruled against Boehringer Ingelheim’s legal challenge to Medicare’s authority to negotiate lower drug prices. […]
Press Releases
Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation WASHINGTON, D.C. — Oral arguments were presented today in the case brought by Boehringer Ingelheim Pharmaceuticals challenging Medicare’s authority to negotiate lower drug prices for patients. During the proceedings, the judge expressed skepticism about the harm the pharmaceutical […]
Press Releases
Patients For Affordable Drugs Responds to AstraZeneca’s Plan to Challenge March 1, 2024 Decision on Its Lawsuit to Stop Medicare Negotiation Program WASHINGTON D.C. — The ongoing legal assault on Medicare negotiation continues as AstraZeneca has filed a notice to appeal a federal judge’s ruling against the company’s lawsuit to overturn the program. AstraZeneca’s blockbuster drug, […]
Press Releases
Federal Court Rejects Big Pharma’s “Strongest Arguments” Challenging Constitutionality of Medicare Negotiation Program, Marking Another Win For Patients WASHINGTON, D.C. — Dealing a major blow to Big Pharma’s efforts to block Medicare from negotiating drug prices, a federal district court in New Jersey has ruled against constitutional challenges brought by pharmaceutical giants Bristol Myers Squibb […]